LONDON, GB / ACCESS Newswire / March 28, 2025 / Black Book Market Research, a leading independent and unbiased technology ...

BETHESDA, MARYLAND / ACCESS Newswire / March 28, 2025 / Solaxa Inc., a biopharmaceutical public benefit corporation focused on rare neurological conditions, has announced plans to conduct a ...

SALT LAKE CITY, UTAH / ACCESS Newswire / March 28, 2025 / PointClickCare, a leading healthcare technology platform enabling meaningful collaboration across the care continuum, and VistaRx, a ...

Find out the change in Physiotherapy DUBAI, UAE / ACCESS Newswire / March 28, 2025 / Since the immerge of healthcare innovation and technology, there has been significant change that's complementing ...

VANCOUVER, BC / ACCESS Newswire / March 28, 2025 / UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) ("UniDoc" or the "Company"), announces that, further to its news release dated March 19, 2025, ...

Eli Lilly and Company (LLY) has expanded its LillyDirect digital healthcare platform to offer connections to independent ...

The Global Nutraceuticals Market valued at $416 billion (2021), is expected to witness a growth rate of 8-9% in the next five years.Need for dietary and food supplements stems from a sedentary ...

Molecure achieved key milestones in the development of its innovative therapies in 2024 and plans to accelerate research and development in its most advanced clinical programs: OATD-01 and OATD-02. A ...

After 15 years as the PM Society Digital Awards, and after taking feedback from our membership, this successful event has evolved its name and sharpened its focus on impact and innovation.

Advancing sustainability in laboratory operations~ Driving environmental conservation through responsibility, collaboration, and innovation ~ Broughton, a leading analytical testing and consultancy ...

Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has acquired a majority interest in Aurion Biotech, Inc., a clinical-stage company ...

Moderna, Inc. (NASDAQ:MRNA) today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has granted marketing authorization for mRESVIA (mRNA-1345), indicated for ...